Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.
暂无分享,去创建一个
A. Mirzabekov | V. Shick | V. Yuferov | M. Kreek | D. Proudnikov | Y Lysov | A Mirzabekov | Y. Lysov | M J Kreek | V Yuferov | D Proudnikov | K S LaForge | V Shick | R Spangler | K. Laforge | R. Spangler | Andrei D. Mirzabekov | Valentin Shick | Yuri Lysov
[1] J. Gelernter,et al. Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). , 1998, Alcoholism, clinical and experimental research.
[2] K. Kendler,et al. Cocaine use, abuse and dependence in a population-based sample of female twins , 1998, British Journal of Psychiatry.
[3] M. Hoehe,et al. The human µ opioid receptor gene: 5´ regulatory and intronic sequences , 1998, Journal of Molecular Medicine.
[4] A. Mirzabekov,et al. DNA sequencing by hybridization to microchip octa-and decanucleotides extended by stacked pentanucleotides. , 1996, Nucleic acids research.
[5] W. Berrettini,et al. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse , 1997, Addiction biology.
[6] A. Frantz,et al. EFFECTS OF CHRONIC EXOGENOUS OPIOID ADMINISTRATION ON LEVELS OF ONE ENDOGENOUS OPIOID (β-ENDORPHIN) IN MAN , 1981 .
[7] H. Jansen,et al. Altered Hematopoiesis, Behavior, and Sexual Function in μ Opioid Receptor–deficient Mice , 1997, The Journal of experimental medicine.
[8] G. Pasternak. Pharmacological mechanisms of opioid analgesics. , 1993, Clinical neuropharmacology.
[9] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[10] A. Mirzabekov,et al. Immobilization of DNA in polyacrylamide gel for the manufacture of DNA and DNA-oligonucleotide microchips. , 1998, Analytical biochemistry.
[11] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[12] W. Vogel,et al. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains , 1994, Nature Genetics.
[13] K. Itakura,et al. Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Mirzabekov,et al. Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. , 1998, Nucleic acids research.
[15] X. Estivill,et al. SSCP analysis: A blind sensitivity trial , 1997, Human mutation.
[16] M. Kreek,et al. CHRONIC USE OF OPIOIDS AND ANTIPSYCHOTIC DRUGS: SIDE EFFECTS, EFFECTS ON ENDOGENOUS OPIOIDS, AND TOXICITY * , 1982, Annals of the New York Academy of Sciences.
[17] L Peltonen,et al. Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.
[18] B. Mason,et al. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. , 1994, Alcoholism, clinical and experimental research.
[19] K Kontula,et al. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.
[20] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[21] G F Koob,et al. Drug dependence: stress and dysregulation of brain reward pathways. , 1998, Drug and alcohol dependence.
[22] L. Peltonen,et al. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. , 1998, Human molecular genetics.
[23] H. Schulman,et al. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] J. Long,et al. μ opioid receptor gene variants: lack of association with alcohol dependence , 1997, Molecular Psychiatry.
[25] N. Chiorazzi,et al. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. , 1989, The Journal of pharmacology and experimental therapeutics.
[26] M. Kreek,et al. Chronic cocaine alters brain mu opioid receptors , 1992, Brain Research.
[27] M. Tsuang,et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. , 1998, Archives of general psychiatry.
[28] S. P. Fodor,et al. Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.
[29] S. Faraone,et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. , 1996, American journal of medical genetics.
[30] J A Tischfield,et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Grompe,et al. The rapid detection of unknown mutations in nucleic acids , 1993, Nature genetics.
[32] C. Kozak,et al. Murine chromosomal location of the mu and kappa opioid receptor genes. , 1994, Genomics.
[33] D. Lykken,et al. Heterogeneity in the inheritance of alcoholism. A study of male and female twins. , 1991, Archives of general psychiatry.
[34] M. Kreek,et al. MEDICAL COMPLICATIONS IN METHADONE PATIENTS * , 1978, Annals of the New York Academy of Sciences.
[35] C. Robert Cloninger,et al. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. , 1981, Archives of general psychiatry.
[36] D. Yandell,et al. How sensitive is PCR‐SSCP? , 1993, Human mutation.
[37] J. Crabbe,et al. Identifying genes for alcohol and drug sensitivity: recent progress and future directions , 1999, Trends in Neurosciences.
[38] M. Kreek. Long-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Antagonists and Partial Agonists , 1996 .
[39] R. Cadoret,et al. Adoption study demonstrating two genetic pathways to drug abuse. , 1995, Archives of general psychiatry.
[40] Lysov YuP,et al. A method for DNA sequencing by hybridization with oligonucleotide matrix. , 1991, DNA sequence : the journal of DNA sequencing and mapping.
[41] B. Cox,et al. Effect of Chronic Cocaine Treatment on μ‐ and δ‐Opioid Receptor mRNA Levels in Dopaminergically Innervated Brain Regions , 1996 .
[42] James L. Winkler,et al. Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.
[43] N. Shen,et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.
[44] L. Bare,et al. Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brain , 1994, FEBS letters.
[45] M. Kreek,et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. , 1998, Alcoholism, clinical and experimental research.
[46] S. O’Brien,et al. Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.
[47] Robert F. Dannals,et al. Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving , 1996, Nature Medicine.
[48] A. Cavalli,et al. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. , 1998, Brain research. Molecular brain research.
[49] A. Mirzabekov,et al. Sequence analysis by hybridization with oligonucleotide microchip: identification of beta-thalassemia mutations. , 1997, Gene.
[50] H. Takagi. Advances in Endogenous and Exogenous Opioids , 1982 .
[51] W. Vogel,et al. Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice , 1996, Psychiatric genetics.
[52] J. Belknap,et al. The genetics of pain and pain inhibition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Khrapko,et al. An oligonucleotide hybridization approach to DNA sequencing , 1989, FEBS letters.
[54] B. Rounsaville,et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.
[55] E. Ochoa Mangado. [Naltrexone in the treatment of alcohol dependence]. , 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.
[56] K. Hayashi,et al. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. , 1991, PCR methods and applications.
[57] S. Bergeson,et al. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. , 1995, Life sciences.
[58] S. P. Fodor,et al. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.
[59] A. Mirzabekov,et al. DNA analysis and diagnostics on oligonucleotide microchips. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Kreek. Long-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Agonists , 1996 .
[61] V. Yuferov,et al. Acute “binge” cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system , 1999, Brain Research Bulletin.
[62] E. Southern,et al. Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models. , 1992, Genomics.
[63] A. Mirzabekov,et al. Polymorphism analysis and gene detection by minisequencing on an array of gel-immobilized primers. , 1999, Nucleic acids research.
[64] I. Sora,et al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Syvänen. From gels to chips: “Minisequencing” primer extension for analysis of point mutations and single nucleotide polymorphisms , 1999, Human mutation.
[66] M. Smolka,et al. Human μ‐Opioid Receptor Variation and Alcohol Dependence , 1998 .
[67] C. Nusbaum,et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.
[68] J. Crabbe,et al. Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred Mice a , 1992, Annals of the New York Academy of Sciences.
[69] M. Kreek. Medical safety and side effects of methadone in tolerant individuals. , 1991, Journal of psychoactive drugs.
[70] I. Sora,et al. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[71] C. Schuster,et al. Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach. , 1996 .
[72] L. Bierut,et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. , 1998, Archives of general psychiatry.
[73] B. K. Pal,et al. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[74] M. Kreek. Opiates, opioids and addiction. , 1996, Molecular psychiatry.
[75] M. Kreek,et al. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. , 1994, Neuroreport.
[76] G. Uhl,et al. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.
[77] K. Merikangas,et al. Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.
[78] J. Culpepper-Morgan,et al. Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal. , 1997, Metabolism: clinical and experimental.
[79] E. Lander,et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .
[80] V. Florentiev,et al. Regioselective immobilization of short oligonucleotides to acrylic copolymer gels. , 1996, Nucleic acids research.
[81] C. Bottema,et al. Characterization of polymerase chain reaction amplification of specific alleles. , 1990, Analytical biochemistry.
[82] Dole Vp,et al. Narcotic blockade. 1966. , 1991 .
[83] Brigitte L. Kieffer,et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.
[84] K. Kendler,et al. Hallucinogen, opiate, sedative and stimulant use and abuse in a population‐based sample of female twins , 1999, Acta psychiatrica Scandinavica.
[85] A. Mirzabekov,et al. Manual manufacturing of oligonucleotide, DNA, and protein microchips. , 1997, Analytical biochemistry.
[86] M. Kreek,et al. NALOXONE, A SPECIFIC OPIOID ANTAGONIST, REVERSES CHRONIC IDIOPATHIC CONSTIPATION , 1983, The Lancet.
[87] M. Kreek,et al. Narcotic blockade. , 1966, Archives of internal medicine.
[88] B. Mason,et al. A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .
[89] S. Green,et al. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.